Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 More is better: a multimodality approach to cancer cachexia.

Literature DB >> 20133501

More is better: a multimodality approach to cancer cachexia.

Egidio Del Fabbro.

Abstract

Entities: Disease

Mesh：

Year: 2010 PMID： 20133501 PMCID： PMC3227946 DOI： 10.1634/theoncologist.2010-0019

Source DB: PubMed Journal: Oncologist ISSN： 1083-7159

× No keyword cloud information.

15 in total

1. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.

Authors: Aminah Jatoi; Shaker R Dakhil; Phuong L Nguyen; Jeff A Sloan; John W Kugler; Kendrith M Rowland; Gamini S Soori; Donald B Wender; Tom R Fitch; Paul J Novotny; Charles L Loprinzi
Journal: Cancer Date: 2007-09-15 Impact factor: 6.860

2. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.

Authors: Aminah Jatoi; Harold E Windschitl; Charles L Loprinzi; Jeff A Sloan; Shaker R Dakhil; James A Mailliard; Sarode Pundaleeka; Carl G Kardinal; Tom R Fitch; James E Krook; Paul J Novotny; Brad Christensen
Journal: J Clin Oncol Date: 2002-01-15 Impact factor: 44.544

3. Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.

Authors: Giovanni Mantovani; Antonio Macciò; Clelia Madeddu; Roberto Serpe; Elena Massa; Mariele Dessì; Filomena Panzone; Paolo Contu
Journal: Oncologist Date: 2010-02-15

4. Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning.

Authors: Kent Lundholm; Ulla Körner; Lena Gunnebo; Petra Sixt-Ammilon; Marita Fouladiun; Peter Daneryd; Ingvar Bosaeus
Journal: Clin Cancer Res Date: 2007-05-01 Impact factor: 12.531

5. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer.

Authors: Benjamin H L Tan; Laura A Birdsell; Lisa Martin; Vickie E Baracos; Kenneth C H Fearon
Journal: Clin Cancer Res Date: 2009-11-03 Impact factor: 12.531

6. Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia.

Authors: Tugba Yavuzsen; Declan Walsh; Mellar P Davis; Jordanka Kirkova; Tao Jin; Susan LeGrand; Ruth Lagman; Lesley Bicanovsky; Bassam Estfan; Bushra Cheema; Abdo Haddad
Journal: Support Care Cancer Date: 2009-04-07 Impact factor: 3.603

7. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.

Authors: Aminah Jatoi; Kendrith Rowland; Charles L Loprinzi; Jeff A Sloan; Shaker R Dakhil; Neil MacDonald; Bruno Gagnon; Paul J Novotny; James A Mailliard; Teresita I L Bushey; Suresh Nair; Brad Christensen
Journal: J Clin Oncol Date: 2004-06-15 Impact factor: 44.544

8. Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group.

Authors: Federico Bozzetti; Luigi Mariani
Journal: JPEN J Parenter Enteral Nutr Date: 2008-12-24 Impact factor: 4.016

9. Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: a pilot study.

Authors: Leandro C A Cerchietti; Alfredo H Navigante; Guillermo D Peluffo; Miriam J Diament; Isabel Stillitani; Slobodanka A Klein; Maria E Cabalar
Journal: J Pain Symptom Manage Date: 2004-01 Impact factor: 3.612

10. Association between megestrol acetate treatment and symptomatic adrenal insufficiency with hypogonadism in male patients with cancer.

Authors: Rony Dev; Egidio Del Fabbro; Eduardo Bruera
Journal: Cancer Date: 2007-09-15 Impact factor: 6.860

4 in total